3.40Open4.00Pre Close99 Volume1.77K Open Interest15.00Strike Price33.55KTurnover137.87%IV9.38%PremiumAug 16, 2024Expiry Date2.20Intrinsic Value100Multiplier25DDays to Expiry1.20Extrinsic Value100Contract SizeAmericanOptions Type-0.5983Delta0.0838Gamma3.94Leverage Ratio-0.0345Theta-0.0065Rho-2.36Eff Leverage0.0130Vega
Sage Therapeutics Stock Discussion
oooooo
Gapping up
$Salesforce(CRM.US)$ jumped 6.2% following its earnings beat after the bell Wednesday. Adjusted earnings per share came in at $2.12 for the second quarter, versus the consensus estimate of $1.90, per Refinitiv. Revenue was $8.60 billion, topping the $8.53 expected. Goldman Sachs subsequently hiked its price target by $15 to $340 a share, suggestions 58% upside.
$UBS Group(UBS.US)$ popp...
follow for daily watchlist 🚀
Great entry point. As long as it is approved and on the market, it will be open for off-label use for MDD if someone really wants it.
However MDD 一般抑郁症 is not approved. Although they are not serious enough for MDD. MDD means huge money. And people with MDD typically take pills for years. Guess what, wall street and elites, they know mental health better than you
Now no huge money but just big mon...
No comment yet